Subgroup Analyses from a Phase 3, Open-Label, Randomized Study of Eribulin Mesylate Versus Capecitabine in Pretreated Patients with Advanced or Metastatic Breast Cancer

• Chris Twelves,
• Ahmad Awada,
• Javier Cortes,
• Louise Yelle,
• Galina Velikova,
• Martin S. Olivo,
• James Song,
• Corina E. Dutcus,
• Peter A. Kaufman

Affiliations

Chris Twelves

Ahmad Awada

Javier Cortes

Louise Yelle

Galina Velikova

Martin S. Olivo

James Song

Corina E. Dutcus

Peter A. Kaufman